# Merz Pharma

the complexing-protein-free "naked toxin" BoNT-A, manufactured via Merz's proprietary purification technology that removes accessory proteins during production; approved in 79 countries for therapeutic and aesthetic indications, with EU EMA submission (January 26,…

Source: https://en.bioecon.ru/companies/merz-pharma/
Updated: 2026-08-15

- Country: Germany

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Revenue | EUR 1.3434 billion (fiscal year 2021/22) | https://www.merz.com/blog/news/alternative-test-method-for-botulinum-neurotoxin-now-approved-in-europe/, https://www.merz.com/blog/news/fiscal-year-ups-downs/ |
| Production site | Dessau, Germany | https://www.merz.com/neurotoxins/, https://www.merz.com/our-businesses/therapeutics/ |
| Regulatory approval | Xeomin (incobotulinumtoxinA) has various approvals including FDA (2011, 2024) and Japan MHLW (2020) for indications such as glabellar lines, upper facial lines, and limb spasticity | https://finance.yahoo.com/sectors/healthcare/articles/xeomin-sales-forecast-market-size-081800994.html, https://merztherapeutics.com/teijin-receives-marketing-approval-for-merzs-xeomin-botulinum-toxin-type-a-in-japan/, https://mineclinic.com/blog/skin/what-is-xeomin-complete-guide/, https://www.delveinsight.com/report-store/xeomin-sales-forecast-and-market-size-analysis, https://www.researchandmarkets.com/reports/6236434/xeomin-sales-forecast-market-size-analysis |
| Certification | Great Place to Work Certification (Merz Therapeutics North America, 2023) | https://merztherapeutics.com/us/merz-therapeutics-north-america-earns-2023-great-place-to-work-certification/ |
| Funding | Not publicly specified as a standalone funding round for this private, long-established company; consolidated financial results are reported annually. [medium confidence] | https://www.delveinsight.com/report-store/xeomin-sales-forecast-and-market-size-analysis, https://www.researchandmarkets.com/reports/6236434/xeomin-sales-forecast-market-size-analysis |
| Capacity | Specific numerical capacity is not publicly disclosed; manufacturing utilizes proprietary XTRACT purification technology in a dedicated facility in Dessau. [medium confidence] | https://dataintelo.com/report/global-botulinum-toxin-injections-market, https://www.merz.com/neurotoxins/, https://www.merz.com/our-businesses/therapeutics/ |

Independent sources: dataintelo.com, delveinsight.com, finance.yahoo.com, merztherapeutics.com, mineclinic.com, researchandmarkets.com

## Technologies

- [Recombinant botulinum toxin (biosynthetic Botox)](https://en.bioecon.ru/technology/recombinant-botulinum-toxin/)